Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department

Pediatric Infectious Disease Journal

Volumn 26, Issue 8, 2007, Pages 672-677

  Andreola, Barbara ^a   Bressan, Silvia ^a   Callegaro, Silvia ^a   Liverani, Anna ^a   Plebani, Mario ^a   Da Dalt, Liviana ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

C reactive protein; Children; Fever; Leukocytes; Procalcitonin

Indexed keywords

C REACTIVE PROTEIN; PROCALCITONIN;

AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE MARKER; DISEASE SEVERITY; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HUMAN; INFANT; LEUKOCYTE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; MULTIVARIATE ANALYSIS; NEUTROPHIL COUNT; NEWBORN; PEDIATRIC WARD; PRESCHOOL CHILD; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE;

BACTERIAL INFECTIONS; C-REACTIVE PROTEIN; CALCITONIN; CHILD, PRESCHOOL; EMERGENCY SERVICE, HOSPITAL; FEMALE; FEVER OF UNKNOWN ORIGIN; HUMANS; INFANT; INFANT, NEWBORN; LEUKOCYTE COUNT; LOGISTIC MODELS; MALE; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; SENSITIVITY AND SPECIFICITY;

EID: 34548715956     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/INF.0b013e31806215e3     Document Type: Article

References (38)

1. McCarthy PL. Fever. Pediatr Rev. 1998;19:401-408.
2. Baraff LJ, Bass JW, Fleisher GR, et al. Practice guideline for the management of infants and children 0 to 36 months of age with fever without source. Pediatrics. 1993;92:1-12.
3. Baraff LJ. Management of fever without source in infants and children. Ann Emerg Med. 2000;36:602-614.
4. Bleeker SE, Moons KGM, Lubsen GD, Grobbee DE, Moll HA. Predicting serious bacterial infection in children with fever without apparent source. Acta Paediatr. 2001;90:1226-1232.
5. Maheshwari N. How useful is C-reactive protein in detecting occult bacterial infection in young children with fever without apparent focus? Arch Dis Child. 2006;91:533-535.
6. Bonadio WA, McElroy K, Jacopy PL, Smith D. Relationship of fever magnitude to rate of serious bacterial infections in infants aged 4-8 weeks. Clin Pediatr (Phila). 1991;30:478-480.
7. McCarthy PL, Scarpe MR, Spiesel SZ, et al. Observation scale to identify serious illness in febrile children. Pediatrics. 1982;70:802-809.
8. McCarthy PL, Lembo RM, Baron MA, Fink HD, Cicchetti DV. Predictive value of abnormal physical examination findings in ill-appearing and well-appearing febrile children. Pediatrics. 1985;76:167-171.
9. Baker MD, Avner JR, Bell LM. Failure of infant observation scale in detecting serious illness in febrile, 4 to 8 week-old infants. Pediatrics. 1990;85:1040-1043.
10. Pulliam PN, Attia MW, Cronan KM. C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. Pediatrics. 2001;108:1275-1279.
11. Gendrel D, Raymond J, Coste J, et al. Comparison of procalcitonin with C-reactive protein, interleukin-6 and interferon-alpha for differentiation of bacterial versus viral infections. Pediatr Infect Dis J. 1999;18:875-881.
12. Hatherill M, Tibby SM, Sykes K, Turner C, Murdoch IA. Diagnostic marker of infection: comparison of procalcitonin with C reactive protein and leucocyte count. Arch Dis Child. 1999;81:417-421.
13. Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J. 2000;19:679-688.
14. van Rossum AMC, Wulkan RW, Oudesluys-Murphy. Procalcitonin as an early marker of infection in neonates and children. Lancet Infect Dis. 2004;4:620-630.
15. Hsiao AL, Baker MD. Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children. Curr Opin Pediatr. 2005;17:56-61.
16. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J. 1997;16:735-746.
17. Du Clos TW. Function of C-reactive protein. Ann Med. 2000;32:274-278.
18. Dandona P, Nix D, Wilson MF, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab. 1994;79:1605-1608.
19. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care. 2003;31:1250-1256.
20. Campbell G. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med. 1994;13:499-508.
21. Isaacman DJ, Burke BL. Utility of the serum C-reactive protein for detection of occult bacterial infection in children. Arch Pediatr Adolesc Med. 2002;156:905-909.
22. Galetto-Lacour A, Gervaix A, Zamora SA, et al. Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infectionsin children with fever without localising signs. Eur J Pediatr. 2001;160:95-100.
23. Galetto-Lacour A, Zamora SA, Gervaix A. Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. Pediatrics. 2003;112:1054-1060.
24. Putto A, Ruuskanen O, Meurman O, et al. C-reactive protein in the evaluation of febrile illness. Arch Dis Child 1986;61:24-29.
25. Peltola H, Jakkola M. C-reactive protein in early detection of bacteremic versus viral infections in immunocompetent and compromised children. J Pediatr. 1988;113:641-646.
26. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patiens with sepsis and infection. Lancet. 1993;341:515-518.
27. Prat C, Dominguez J, Rodrigo C, et al. Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infections. Pediatr Infect Dis J. 2003;22:963-968.
28. Benador N, Siegrist CA, Gendrel D, et al. Procalcitonin is a marker of severity of renal lesions in pyelonephritis. Pediatrics. 1998;102:1422-1425.
29. Pecile P, Miorin E, Romanello C, et al. Procalcitonin: a marker of severità of acute pyelonephritis among children. Pediatrics. 2004;114:e249-e254.
30. Carrol ED, Newland P, Riordan FA, et al. Procalcitonin as a diagnostic marker of meningococcal disease in children presenting with fever and a rash. Arch Dis Child. 2002;86:282-285.
31. Berger RM, Berger MY, VanSteensel-Moll HA, Dzoljic-Danilovic G, Derksen-Lubsen G. A predictive model to estimate the risk of serious bacterial infections in febrile infants. Eur J Pediatr 1996;155:468-473.
32. Hsiao AL, Chen L, Baker MD. Incidence and predictors of serious bacterial infections among 57- to 180-day-old infants. Pediatrics. 2006;117:1695-1701.
33. Fernandez Lopez A, Luaces Cubells C, Valls Tolosa C, et al. Procalcitonina para el diagnostico precoz de infeccion bacteriana invasive en el lactante febril. An Esp Pediatric. 2001;55:321-328.
34. Fernandez Lopez A, Luaces Cubells C, Garcia Garcia JJ, Fernandez Pou J. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker. Pediatr Infect Dis J. 2003;22:895-903.
35. Lee GM, Harper MB. Risk of bacteremia for febrile young children in the post Haemophilus influenzae type B era. Arch Pediatr Adolesc Med. 1998;152:624-628.
36. Alpern ER, Alessandrini EA, Bell LM, Shaw KN, McGowan KL. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection and outcome. Paediatrics. 2000;106:505-511.
37. Whitney CG. The potential of pneumococcal conjugate vaccines for children. Pediatr Infect Dis J. 2002;21:961-970.
38. Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737-1746.